Inter-relations between osteoarthritis and metabolic syndrome: A common link?

Biochimie

Volumn 121, Issue , 2016, Pages 238-252

  Le Clanche, S ^a,b   Bonnefont Rousselot, D ^b,c,d   Sari Ali, E ^d   Rannou, F ^a,e   Borderie, D ^a,b,e  

^a Pharmacologie Toxicologie et Signalisation Cellulaire   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c Sorbonne Universités   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Hôpital Cochin ^*  (France)

Author keywords

Dyslipidemia; Hyperglycemia; Metabolic syndrome; Mitochondrial dysfunction; Obesity; Osteoarthritis

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GLUCOSE; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; ADIPOCYTOKINE;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSLIPIDEMIA; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIPID DIET; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OSTEOARTHRITIS; REVIEW; CHONDROCYTE; COMPLICATION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADIPOKINES; CHONDROCYTES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; METABOLIC SYNDROME X; OSTEOARTHRITIS;

EID: 84952802664     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.12.008     Document Type: Review

References (151)

1. T. Vos, A.D. Flaxman, M. Naghavi, and et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 9859 2012 2163 2196 10.1016/S0140-6736(12)61729-2
2. K.D. Muirden Community Oriented Program for the Control of Rheumatic Diseases: studies of rheumatic diseases in the developing world Curr. Opin. Rheumatol. 17 2 2005 153 156
3. S.K. Das, and A. Farooqi Osteoarthr. Best. Pract. Res. Clin. Rheumatol. 22 4 2008 657 675 10.1016/j.berh.2008.07.002
4. M.B. Goldring, and K.B. Marcu Cartilage homeostasis in health and rheumatic diseases Arthritis Res. Ther. 11 3 2009 224 10.1186/ar2592
5. N. Verzijl, J. DeGroot, S.R. Thorpe, and et al. Effect of collagen turnover on the accumulation of advanced glycation end products J. Biol. Chem. 275 50 2000 39027 39031 10.1074/jbc.M006700200
6. T.E. Swingler, J.G. Waters, R.K. Davidson, and et al. Degradome expression profiling in human articular cartilage Arthritis Res. Ther. 11 3 2009 R96 10.1186/ar2741
7. Q. Zhuo, W. Yang, J. Chen, and Y. Wang Metabolic syndrome meets osteoarthritis Nat. Rev. Rheumatol. 8 12 2012 729 737 10.1038/nrrheum.2012.135
8. J.W.J. Bijlsma, F. Berenbaum, and F.P.J.G. Lafeber Osteoarthritis: an update with relevance for clinical practice Lancet 377 9783 2011 2115 2126 10.1016/S0140-6736(11)60243-2
9. R.A. Puenpatom, and T.W. Victor Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data Postgrad. Med. 121 6 2009 9 20 10.3810/pgm.2009.11.2073
10. E. Yusuf Metabolic factors in osteoarthritis: obese people do not walk on their hands Arthritis Res. Ther. 14 4 2012 123 10.1186/ar3894
11. A.R. Baker, R.J. Goodloe, E.K. Larkin, and et al. Multivariate association analysis of the components of metabolic syndrome from the Framingham Heart Study BMC Proc. 3 Suppl. 7 2009 S42
12. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet. Med. J. Br. Diabet. Assoc. 15 7 1998 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
13. R.H. Eckel, S.M. Grundy, and P.Z. Zimmet The metabolic syndrome Lancet 365 9468 2005 1415 1428 10.1016/S0140-6736(05)66378-7
14. B. Balkau, and M.A. Charles Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet. Med. J. Br. Diabet. Assoc. 16 5 1999 442 443
15. K.G.M.M. Alberti, R.H. Eckel, S.M. Grundy, and et al. International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 16 2009 1640 1645 10.1161/CIRCULATIONAHA.109.192644
16. J. Redon, R. Cifkova, S. Laurent, and et al. Scientific Council of the European Society of Hypertension. The metabolic syndrome in hypertension: European society of hypertension position statement J. Hypertens. 26 10 2008 1891 1900 10.1097/HJH.0b013e328302ca38
17. G.P. Carnevale Schianca, G.P. Fra, M. Steffanini, and et al. Impaired glucose metabolism in hypertensive patients with/without the metabolic syndrome Eur. J. Intern Med. 25 5 2014 477 481 10.1016/j.ejim.2014.04.006
18. T. Hayashi, E.J. Boyko, D.L. Leonetti, and et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans Ann. Intern Med. 140 12 2004 992 1000
19. W. Zidek, L. Naditch-Brûlé, S. Perlini, C. Farsang, and S.E. Kjeldsen Blood pressure control and components of the metabolic syndrome: the GOOD survey Cardiovasc Diabetol. 8 2009 51 10.1186/1475-2840-8-51
20. R. Marks, and J.P. Allegrante Comorbid disease profiles of adults with end-stage hip osteoarthritis Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 8 4 2002 CR305 CR309
21. J. Morović-Vergles, L. Salamon, D. Marasović-Krstulović, and et al. Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease? Rheumatol. Int. 33 5 2013 1185 1192 10.1007/s00296-012-2522-1
22. P.L. Huang, Z. Huang, H. Mashimo, and et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 6546 1995 239 242 10.1038/377239a0
23. H. Imhof, I. Sulzbacher, S. Grampp, C. Czerny, S. Youssefzadeh, and F. Kainberger Subchondral bone and cartilage disease: a rediscovered functional unit Invest Radiol. 35 10 2000 581 588
24. D.M. Findlay Vascular pathology and osteoarthritis Rheumatol. Oxf Engl. 46 12 2007 1763 1768 10.1093/rheumatology/kem191
25. J.I. Aguirre, L.I. Plotkin, S.A. Stewart, and et al. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss J. Bone Min. Res. Off. J. Am. Soc. Bone Min. Res. 21 4 2006 605 615 10.1359/jbmr.060107
26. D.T. Felson, and C.E. Chaisson Understanding the relationship between body weight and osteoarthritis Baillières Clin. Rheumatol. 11 4 1997 671 681
27. V. Abella, M. Scotece, J. Conde, and et al. Adipokines, metabolic syndrome and rheumatic diseases J. Immunol. Res. 2014 2014 10.1155/2014/343746
28. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 6505 1994 425 432 10.1038/372425a0
29. M.A. Pelleymounter, M.J. Cullen, M.B. Baker, and et al. Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 5223 1995 540 543
30. R.T. Turner, S.P. Kalra, C.P. Wong, and et al. Peripheral leptin regulates bone formation J. Bone Min. Res. Off. J. Am. Soc. Bone Min. Res. 28 1 2013 22 34 10.1002/jbmr.1734
31. J.E. Reseland, U. Syversen, I. Bakke, and et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization J. Bone Min. Res. Off. J. Am. Soc. Bone Min. Res. 16 8 2001 1426 1433 10.1359/jbmr.2001.16.8.1426
32. M. Tang, J.J. Potter, and E. Mezey Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation Biochem. Biophys. Res. Commun. 297 4 2002 906 911
33. S. Stenholm, A. Koster, D.E. Alley, and et al. Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study Clin. Endocrinol. (Oxf) 73 1 2010 55 65 10.1111/j.1365-2265.2009.03742.x
34. P. Chedraui, F.R. Pérez-López, G.S. Escobar, and et al. Research Group for the Omega Women's Health Project. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome Maturitas June 2014 10.1016/j.maturitas.2014.06.008
35. Y. Figenschau, G. Knutsen, S. Shahazeydi, O. Johansen, and B. Sveinbjörnsson Human articular chondrocytes express functional leptin receptors Biochem. Biophys. Res. Commun. 287 1 2001 190 197 10.1006/bbrc.2001.5543
36. T. Simopoulou, K.N. Malizos, D. Iliopoulos, and et al. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 15 8 2007 872 883 10.1016/j.joca.2007.01.018
37. G. Sweeney Leptin signaling Cell Signal. 14 8 2002 655 663
38. A. Koskinen, K. Vuolteenaho, R. Nieminen, T. Moilanen, and E. Moilanen Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients Clin. Exp. Rheumatol. 29 1 2011 57 64
39. L.J. Sandell Obesity and osteoarthritis: is leptin the link? Arthritis Rheum. 60 10 2009 2858 2860 10.1002/art.24862
40. K. Vuolteenaho, A. Koskinen, M. Kukkonen, and et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage-mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production Mediat. Inflamm. 2009 2009 345838 10.1155/2009/345838
41. C.A. Karvonen-Gutierrez, S.D. Harlow, P. Mancuso, J. Jacobson, C.F. Mendes de Leon, and B. Nan Association of leptin levels with radiographic knee osteoarthritis among a cohort of midlife women Arthritis Care Res. 65 6 2013 936 944 10.1002/acr.21922
42. R. Ye, and P.E. Scherer Adiponectin, driver or passenger on the road to insulin sensitivity? Mol. Metab. 2 3 2013 133 141 10.1016/j.molmet.2013.04.001
43. M. Okamoto, M. Ohara-Imaizumi, N. Kubota, and et al. Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration Diabetologia 51 5 2008 827 835 10.1007/s00125-008-0944-9
44. A. De Rosa, M.L. Monaco, M. Capasso, and et al. Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects Eur. J. Endocrinol. Eur. Fed. Endocr. Soc. 169 1 2013 37 43 10.1530/EJE-12-1039
45. J. Spranger, A. Kroke, M. Möhlig, and et al. Adiponectin and protection against type 2 diabetes mellitus Lancet 361 9353 2003 226 228 10.1016/S0140-6736(03)12255-6
46. P.-J. Francin, A. Abot, C. Guillaume, and et al. Association between adiponectin and cartilage degradation in human osteoarthritis Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 22 3 2014 519 526 10.1016/j.joca.2014.01.002
47. T.-H. Chen, L. Chen, M.-S. Hsieh, C.-P. Chang, D.-T. Chou, and S.-H. Tsai Evidence for a protective role for adiponectin in osteoarthritis Biochim. Biophys. Acta 1762 8 2006 711 718 10.1016/j.bbadis.2006.06.008
48. Q. Wang, J. Cai, J. Wang, and et al. Down-regulation of adiponectin receptors in osteoarthritic chondrocytes Cell Biochem. Biophys. 70 1 2014 491 497 10.1007/s12013-014-9946-z
49. R. Lago, R. Gomez, M. Otero, and et al. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 16 9 2008 1101 1109 10.1016/j.joca.2007.12.008
50. M.B. Goldring, and F. Berenbaum The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide Clin. Orthop. 427 Suppl 2004 S37 S46
51. D. Hao, M. Li, Z. Wu, Y. Duan, D. Li, and G. Qiu Synovial fluid level of adiponectin correlated with levels of aggrecan degradation markers in osteoarthritis Rheumatol. Int. 31 11 2011 1433 1437 10.1007/s00296-010-1516-0
52. A. Kamińska, E. Kopczyńska, M. Bieliński, A. Borkowska, and R. Junik Visfatin concentrations in obese patients in relation to the presence of newly diagnosed glucose metabolism disorders Endokrynol. Pol. 66 2 2015 108 113 10.5603/EP.2015.0016
53. Y.-H. Chang, D.-M. Chang, K.-C. Lin, S.-J. Shin, and Y.-J. Lee Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review Diabetes Metab. Res. Rev. 27 6 2011 515 527 10.1002/dmrr.1201
54. M. Gosset, F. Berenbaum, C. Salvat, and et al. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis Arthritis Rheum. 58 5 2008 1399 1409 10.1002/art.23431
55. A.L. McNulty, M.R. Miller, S.K. O'Connor, and F. Guilak The effects of adipokines on cartilage and meniscus catabolism Connect. Tissue Res. 52 6 2011 523 533 10.3109/03008207.2011.597902
56. L. Patel, A.C. Buckels, I.J. Kinghorn, and et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem. Biophys. Res. Commun. 300 2 2003 472 476
57. C.M. Steppan, S.T. Bailey, S. Bhat, and et al. The hormone resistin links obesity to diabetes Nature 409 6818 2001 307 312 10.1038/35053000
58. A. Nieva-Vazquez, R. Pérez-Fuentes, E. Torres-Rasgado, J.G. López-López, and J.R. Romero Serum resistin levels are associated with adiposity and insulin sensitivity in obese Hispanic subjects Metab. Syndr. Relat. Disord. 12 2 2014 143 148 10.1089/met.2013.0118
59. N. Iqbal, P. Seshadri, L. Stern, and et al. Serum resistin is not associated with obesity or insulin resistance in humans Eur. Rev. Med. Pharmacol. Sci. 9 3 2005 161 165
60. W.E. Van Spil, P.M.J. Welsing, M. Kloppenburg, and et al. Cross-sectional and predictive associations between plasma adipokines and radiographic signs of early-stage knee osteoarthritis: data from CHECK Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 20 11 2012 1278 1285 10.1016/j.joca.2012.08.001
61. J.H. Lee, T. Ort, K. Ma, and et al. Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 17 5 2009 613 620 10.1016/j.joca.2008.08.007
62. R.H. Unger, and L. Orci Diseases of liporegulation: new perspective on obesity and related disorders FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 15 2 2001 312 321 10.1096/fj.00-0590
63. J.M. McGavock, R.G. Victor, R.H. Unger, and L.S. Szczepaniak American College of Physicians and the American Physiological Society. Adiposity of the heart, revisited Ann. Intern Med. 144 7 2006 517 524
64. T.M. Griffin, J.L. Huebner, V.B. Kraus, Z. Yan, and F. Guilak Induction of osteoarthritis and metabolic inflammation by a very high-fat diet in mice: effects of short-term exercise Arthritis Rheum. 64 2 2012 443 453 10.1002/art.33332
65. M. Iwata, H. Ochi, Y. Hara, and et al. Initial responses of articular tissues in a murine high-fat diet-induced osteoarthritis model: pivotal role of the IPFP as a cytokine fountain PloS One 8 4 2013 e60706 10.1371/journal.pone.0060706
66. R.A. Mooney, E.R. Sampson, J. Lerea, R.N. Rosier, and M.J. Zuscik High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury Arthritis Res. Ther. 13 6 2011 R198 10.1186/ar3529
67. R.A. Stockwell Lipid content of human costal and articular cartilage Ann. Rheum. Dis. 26 6 1967 481 486
68. B. Cillero-Pastor, G. Eijkel, A. Kiss, F.J. Blanco, and R.M.A. Heeren Time-of-flight secondary ion mass spectrometry-based molecular distribution distinguishing healthy and osteoarthritic human cartilage Anal. Chem. 84 21 2012 8909 8916 10.1021/ac301853q
69. M.K. Kosinska, G. Liebisch, G. Lochnit, and et al. A lipidomic study of phospholipid classes and species in human synovial fluid Arthritis Rheum. 65 9 2013 2323 2333 10.1002/art.38053
70. W. De Munter, A.B. Blom, M.M. Helsen, and et al. Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis Arthritis Res. Ther. 15 6 2013 R178 10.1186/ar4367
71. E.N. Blaney Davidson, E.L. Vitters, H.M. van Beuningen, F. a. J. van de Loo, W.B. van den Berg, and P.M. van der Kraan Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation Arthritis Rheum. 56 12 2007 4065 4073 10.1002/art.23034
72. L.A. Collins-Racie, Z. Yang, M. Arai, and et al. Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 17 7 2009 832 842 10.1016/j.joca.2008.12.011
73. B.B. Lowell PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function Cell. 99 3 1999 239 242
74. O. Gavrilova, M. Haluzik, K. Matsusue, and et al. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass J. Biol. Chem. 278 36 2003 34268 34276 10.1074/jbc.M300043200
75. M. Lehrke, and M.A. Lazar The many faces of PPARgamma Cell. 123 6 2005 993 999 10.1016/j.cell.2005.11.026
76. A.K. Agarwal, and A. Garg A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy J. Clin. Endocrinol. Metab. 87 1 2002 408 411 10.1210/jcem.87.1.8290
77. R.A. Hegele, H. Cao, C. Frankowski, S.T. Mathews, and T. Leff PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy Diabetes 51 12 2002 3586 3590
78. D.B. Savage, G.D. Tan, C.L. Acerini, and et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma Diabetes 52 4 2003 910 917
79. F. Vasheghani, R. Monemdjou, H. Fahmi, and et al. Adult cartilage-specific peroxisome proliferator-activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotype Am. J. Pathol. 182 4 2013 1099 1106 10.1016/j.ajpath.2012.12.012
80. F. Vasheghani, Y. Zhang, Y.-H. Li, and et al. PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signaling in the articular cartilage Ann. Rheum. Dis. 74 3 2015 569 578 10.1136/annrheumdis-2014-205743
81. R. Monemdjou, F. Vasheghani, H. Fahmi, and et al. Association of cartilage-specific deletion of peroxisome proliferator-activated receptor γ with abnormal endochondral ossification and impaired cartilage growth and development in a murine model Arthritis Rheum. 64 5 2012 1551 1561 10.1002/art.33490
82. M.W. Twigg, K. Freestone, S. Homer-Vanniasinkam, and S. Ponnambalam The LOX-1 Scavenger receptor and its implications in the treatment of vascular disease Cardiol. Res. Pract. 2012 2012 632408 10.1155/2012/632408
83. T. Goyal, S. Mitra, M. Khaidakov, and et al. Current concepts of the role of oxidized LDL receptors in Atherosclerosis Curr. Atheroscler. Rep. January 2012 10.1007/s11883-012-0228-1
84. P. Luo, M. Yan, E.D. Frohlich, J.L. Mehta, and C. Hu Novel concepts in the genesis of hypertension: role of LOX-1 Cardiovasc Drugs Ther. Spons. Int. Soc. Cardiovasc Pharmacother. 25 5 2011 441 449 10.1007/s10557-011-6337-1
85. M. Yan, J.L. Mehta, and C. Hu LOX-1 and obesity Cardiovasc Drugs Ther. Spons. Int. Soc. Cardiovasc Pharmacother. 25 5 2011 469 476 10.1007/s10557-011-6335-3
86. N. Yamamoto, M. Toyoda, M. Abe, and et al. Lectin-like oxidized LDL receptor-1 (LOX-1) expression in the tubulointerstitial area likely plays an important role in human diabetic nephropathy Intern. Med. Tokyo Jpn. 48 4 2009 189 194
87. M. Nowicki, J. Kosacka, H. Serke, M. Blüher, and K. Spanel-Borowski Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome J. Neurosci. Res. 90 1 2012 122 131 10.1002/jnr.22728
88. P.C. Chui, H.-P. Guan, M. Lehrke, and M.A. Lazar PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1 J. Clin. Invest 115 8 2005 2244 2256 10.1172/JCI24130
89. R. Takanabe-Mori, K. Ono, N. Sowa, and et al. Lectin-like oxidized low-density lipoprotein receptor-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice Biochem. Biophys. Res. Commun. 398 3 2010 576 580 10.1016/j.bbrc.2010.06.123
90. M. Akagi, A. Ueda, T. Teramura, S. Kanata, T. Sawamura, and C. Hamanishi Oxidized LDL binding to LOX-1 enhances MCP-1 expression in cultured human articular chondrocytes Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 17 2 2009 271 275 10.1016/j.joca.2008.06.019
91. S. Kanata, M. Akagi, S. Nishimura, and et al. Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma Biochem. Biophys. Res. Commun. 348 3 2006 1003 1010 10.1016/j.bbrc.2006.07.133
92. T. Simopoulou, K.N. Malizos, and A. Tsezou Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes Clin. Exp. Rheumatol. 25 4 2007 605 612
93. A. Mobasheri Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator Front. Endocrinol. 3 2012 153 10.3389/fendo.2012.00153
94. M. Grayson Nutrigenomics Nature 468 7327 2010 S1 10.1038/468S1a
95. S.C. Rosa, A.T. Rufino, F.M. Judas, C.M. Tenreiro, M.C. Lopes, and A.F. Mendes Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes J. Cell Biochem. 112 10 2011 2813 2824 10.1002/jcb.23196
96. X.-H. Li, L.-L. Du, X.-S. Cheng, and et al. Glycation exacerbates the neuronal toxicity of β-amyloid Cell Death Dis. 4 2013 e673 10.1038/cddis.2013.180
97. E. Shim, and J.P. Babu Glycated albumin produced in diabetic hyperglycemia promotes monocyte secretion of inflammatory cytokines and bacterial adherence to epithelial cells J. Periodontal Res. May 2014 10.1111/jre.12194
98. S.K. Mallipattu, J.C. He, and J. Uribarri Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients Semin. Dial. 25 5 2012 529 538 10.1111/j.1525-139X.2012.01081.x
99. D.L. Vander Jagt Methylglyoxal, diabetes mellitus and diabetic complications Drug Metabol. Drug Interact. 23 1-2 2008 93 124
100. L. Wu, and B.H.J. Juurlink Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells Hypertension 39 3 2002 809 814
101. X. Jia, T. Chang, T.W. Wilson, and L. Wu Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1 PloS One 7 5 2012 e36610 10.1371/journal.pone.0036610
102. X. Wang, X. Jia, T. Chang, K. Desai, and L. Wu Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats J. Hypertens. 26 4 2008 765 772 10.1097/HJH.0b013e3282f4a13c
103. N. Verzijl, J. DeGroot, Z.C. Ben, and et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis Arthritis Rheum. 46 1 2002 114 123 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P
104. P.A.J.M. Vos, J. DeGroot, A.D. Barten-van Rijbroek, and et al. Elevation of cartilage AGEs does not accelerate initiation of canine experimental osteoarthritis upon mild surgical damage J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 30 9 2012 1398 1404 10.1002/jor.22092
105. T.L. Willett, R. Kandel, J.N.A. De Croos, N.C. Avery, and M.D. Grynpas Enhanced levels of non-enzymatic glycation and pentosidine crosslinking in spontaneous osteoarthritis progression Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 20 7 2012 736 744 10.1016/j.joca.2012.03.012
106. R.F. Loeser, R.R. Yammani, C.S. Carlson, and et al. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis Arthritis Rheum. 52 8 2005 2376 2385 10.1002/art.21199
107. S.D. Yan, A.M. Schmidt, G.M. Anderson, and et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J. Biol. Chem. 269 13 1994 9889 9897
108. A. Schmitt, K. Bigl, I. Meiners, and J. Schmitt Induction of reactive oxygen species and cell survival in the presence of advanced glycation end products and similar structures Biochim. Biophys. Acta 1763 9 2006 927 936 10.1016/j.bbamcr.2006.07.006
109. A. Raucci, S. Cugusi, A. Antonelli, and et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 22 10 2008 3716 3727 10.1096/fj.08-109033
110. A.Z. Kalea, A.M. Schmidt, and B.I. Hudson RAGE: a novel biological and genetic marker for vascular disease Clin. Sci. Lond Engl. 1979 116 8 2009 621 637 10.1042/CS20080494
111. M. Monden, H. Koyama, Y. Otsuka, and et al. Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2 Diabetes 62 2 2013 478 489 10.2337/db11-1116
112. K.H.J. Gaens, G.H. Goossens, P.M. Niessen, and et al. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance Arterioscler. Thromb. Vasc. Biol. 34 6 2014 1199 1208 10.1161/ATVBAHA.113.302281
113. B.I. Hudson, C. Dong, H. Gardener, and et al. Serum levels of soluble receptor for advanced glycation end-products and metabolic syndrome: the Northern Manhattan Study Metabolism June 2014 10.1016/j.metabol.2014.05.011
114. H. Momma, K. Niu, Y. Kobayashi, and et al. Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study Diabetol. Metab. Syndr. 6 1 2014 33 10.1186/1758-5996-6-33
115. F. Berenbaum Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype Ann. Rheum. Dis. 70 8 2011 1354 1356 10.1136/ard.2010.146399
116. G. Schett, A. Kleyer, C. Perricone, and et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study Diabetes Care 36 2 2013 403 409 10.2337/dc12-0924
117. M. Nieves-Plaza, L.E. Castro-Santana, Y.M. Font, A.M. Mayor, and L.M. Vilá Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis. 19 1 2013 1 6 10.1097/RHU.0b013e31827cd578
118. T. Onur, R. Wu, L. Metz, and A. Dang Characterisation of osteoarthritis in a small animal model of type 2 diabetes mellitus Bone Jt. Res. 3 6 2014 203 211 10.1302/2046-3758.36.2000244
119. K.M. Kelley, S.M. Russell, M.L. Matteucci, and C.S. Nicoll An insulin-like growth factor I-resistant state in cartilage of diabetic rats is ameliorated by hypophysectomy. Possible role of metabolism Diabetes 42 3 1993 463 469
120. S.A. Atayde, N.H. Yoshinari, D.P. Nascimento, and et al. Experimental diabetes modulates collagen remodelling of joints in rats Histol. Histopathol. 27 11 2012 1471 1479
121. K. Louati, C. Vidal, F. Berenbaum, and J. Sellam Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis RMD Open 1 1 2015 e000077 10.1136/rmdopen-2015-000077
122. S.C. Rosa, J. Gonçalves, F. Judas, A. Mobasheri, C. Lopes, and A.F. Mendes Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage Arthritis Res. Ther. 11 3 2009 R80 10.1186/ar2713
123. C. Ruiz-Romero, V. Carreira, I. Rego, S. Remeseiro, M.J. López-Armada, and F.J. Blanco Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis Proteomics 8 3 2008 495 507 10.1002/pmic.200700249
124. C.D. Han, I.H. Yang, W.S. Lee, Y.J. Park, and K.K. Park Correlation between metabolic syndrome and knee osteoarthritis: data from the Korean National Health and Nutrition Examination Survey (KNHANES) BMC Public Health 13 2013 603 10.1186/1471-2458-13-603
125. G. Engström, M. Gerhardsson de Verdier, J. Rollof, P.M. Nilsson, and L.S. Lohmander C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study Osteoarthr. Cartil. 17 2 2009 168 173 10.1016/j.joca.2008.07.003
126. M. Massengale, W.M. Reichmann, E. Losina, D.H. Solomon, and J.N. Katz The relationship between hand osteoarthritis and serum leptin concentration in participants of the Third National Health and Nutrition Examination Survey Arthritis Res. Ther. 14 3 2012 R132 10.1186/ar3864
127. J.J. Anderson, and D.T. Felson Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work Am. J. Epidemiol. 128 1 1988 179 189
128. M.I. Frey, E. Barrett-Connor, P.A. Sledge, D.L. Schneider, and M.H. Weisman The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study J. Rheumatol. 23 4 1996 716 722
129. K. Martin, M. Lethbridge-Cejku, D.C. Muller, and et al. Metabolic correlates of obesity and radiographic features of knee osteoarthritis: data from the Baltimore Longitudinal Study of Aging J. Rheumatol. 24 4 1997 702 707
130. S. Monira Hussain, Y. Wang, F.M. Cicuttini, and et al. Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: a prospective cohort study Semin. Arthritis Rheum. 43 4 2014 429 436 10.1016/j.semarthrit.2013.07.013
131. S. Dahaghin, S.M.A. Bierma-Zeinstra, B.W. Koes, J.M.W. Hazes, and H. a. P. Pols Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study Ann. Rheum. Dis. 66 7 2007 916 920 10.1136/ard.2005.045724
132. N. Yoshimura, S. Muraki, H. Oka, and et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study Osteoarthr. Cartil. 20 11 2012 1217 1226 10.1016/j.joca.2012.06.006
133. S.R. Pieczenik, and J. Neustadt Mitochondrial dysfunction and molecular pathways of disease Exp. Mol. Pathol. 83 1 2007 84 92 10.1016/j.yexmp.2006.09.008
134. P. Schrauwen, and M.K.C. Hesselink Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes Diabetes 53 6 2004 1412 1417
135. M. Rossmeisl, I. Syrový, F. Baumruk, P. Flachs, P. Janovská, and J. Kopecký Decreased fatty acid synthesis due to mitochondrial uncoupling in adipose tissue FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 14 12 2000 1793 1800
136. G. Gastaldi, J.P. Giacobino, and J. Ruiz [Metabolic syndrome, a mitochondrial disease?] Rev. Médicale Suisse 4 160 2008 1387 1388 1390-1391
137. E. Nisoli, E. Clementi, M.O. Carruba, and S. Moncada Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ. Res. 100 6 2007 795 806 10.1161/01.RES.0000259591.97107.6c
138. L.M. Sparks, H. Xie, R.A. Koza, and et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle Diabetes 54 7 2005 1926 1933
139. D.E. Kelley, J. He, E.V. Menshikova, and V.B. Ritov Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 10 2002 2944 2950
140. M.A. Alam, and M.M. Rahman Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome J. Diabetes Metab. Disord. 13 2014 60 10.1186/2251-6581-13-60
141. F.J. Blanco, I. Rego, and C. Ruiz-Romero The role of mitochondria in osteoarthritis Nat. Rev. Rheumatol. 7 3 2011 161 169 10.1038/nrrheum.2010.213
142. E. Maneiro, M.A. Martín, M.C. de Andres, and et al. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes Arthritis Rheum. 48 3 2003 700 708 10.1002/art.10837
143. J. Kim, M. Xu, R. Xo, and et al. Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc. 18 3 2010 424 432 10.1016/j.joca.2009.09.008
144. S. Dröse, U. Brandt, I. Wittig, Mitochondrial respiratory chain complexes as sources and targets of thiol-based redox-regulation, Biochim. Biophys. Acta BBA Proteins Proteomics, doi:10.1016/j.bbapap.2014.02.006.
145. C. Vaamonde-García, R.R. Riveiro-Naveira, M.N. Valcárcel-Ares, L. Hermida-Carballo, F.J. Blanco, and M.J. López-Armada Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes Arthritis Rheum. 64 9 2012 2927 2936 10.1002/art.34508
146. B. Cillero-Pastor, I. Rego-Pérez, N. Oreiro, C. Fernandez-Lopez, and F.J. Blanco Mitochondrial respiratory chain dysfunction modulates metalloproteases -1, -3 and -13 in human normal chondrocytes in culture BMC Musculoskelet. Disord. 14 2013 235 10.1186/1471-2474-14-235
147. A.J. Freemont, V. Hampson, R. Tilman, P. Goupille, Y. Taiwo, and J.A. Hoyland Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific Ann. Rheum. Dis. 56 9 1997 542 549
148. G. Escames, L.C. López, J.A. García, L. García-Corzo, F. Ortiz, and D. Acuña-Castroviejo Mitochondrial DNA and inflammatory diseases Hum. Genet. 131 2 2012 161 173 10.1007/s00439-011-1057-y
149. K.J. Wolff, P.S. Ramakrishnan, M.J. Brouillette, and et al. Mechanical stress and ATP synthesis are coupled by mitochondrial oxidants in articular cartilage J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 31 2 2013 191 196 10.1002/jor.22223
150. W. Goodwin, D. McCabe, E. Sauter, and et al. Rotenone prevents impact-induced chondrocyte death J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 28 8 2010 1057 1063 10.1002/jor.21091
151. J.F. Turrens Mitochondrial formation of reactive oxygen species J. Physiol. 552 Pt 2 2003 335 344 10.1113/jphysiol.2003.049478